I may be wrong but I recall both CSL and Baxter had no luck with this some years ago. Not sure if the treatment method was the same though, but yes if it works then demand for blood products will benefit CSL
https://www.fnarena.com/index.php/2013/05/10/csl-analysts-shrug-off-alzheimers-disappointment/
- Forums
- ASX - By Stock
- CSL
- CSL has more upside...
CSL has more upside..., page-3
-
- There are more pages in this discussion • 423 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
|
|||||
Last
$311.27 |
Change
2.085(0.67%) |
Mkt cap ! $149.4B |
Open | High | Low | Value | Volume |
$311.01 | $312.10 | $310.40 | $14.35M | 46.09K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9 | $311.25 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$311.28 | 36 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8 | 311.250 |
4 | 91 | 311.220 |
2 | 40 | 311.210 |
1 | 40 | 311.170 |
1 | 64 | 311.130 |
Price($) | Vol. | No. |
---|---|---|
311.280 | 48 | 3 |
311.290 | 2 | 1 |
311.300 | 3 | 1 |
311.310 | 29 | 1 |
311.350 | 31 | 4 |
Last trade - 10.06am 23/07/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |